We are live on ! Find out more
MYOV

Myovant Sciences Ltd.
MYOV

Delisted

MYOV was delisted on the 9th of March, 2023.

Back to rankings

108 hedge funds and large institutions have $737M invested in Myovant Sciences Ltd. in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 40 increasing their positions, 27 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 27

21% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 19

18% more capital invested

Capital invested by funds: $624M → $737M (+$113M)

4% more funds holding

Funds holding: 104 → 108 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

73% less call options, than puts

Call options by funds: $8.77M | Put options by funds: $32.8M

Holders
108
Holders Change
+4
Holders Change %
+3.85%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
40
Reduced
27
Closed
19
Calls
$8.77M
Puts
$32.8M
Net Calls
-$24M
Net Calls Change
-$87K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$44.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$18.2M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$5.19M
4
Renaissance Technologies
Renaissance Technologies
New York
+$4.78M
5
Millennium Management
Millennium Management
New York
+$4.62M

Top Sellers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$27.6M
2
CAM
Cormorant Asset Management
Massachusetts
-$9.63M
3
TLP
Tri Locum Partners
New York
-$6.61M
4
PC
Pier Capital
Connecticut
-$5.35M
5
OM
Opaleye Management
Massachusetts
-$5.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$4.39M +$102K +4,842 +3%
Citadel Advisors
27
Citadel Advisors
Florida
$4.08M -$155K -7,384 -4%
Goldman Sachs
28
Goldman Sachs
New York
$4.07M -$4.3M -204,342 -53%
Citigroup
29
Citigroup
New York
$4.02M +$3.68M +174,871 +10,795%
BAM
30
Blueshift Asset Management
New Jersey
$3.83M +$3.54M +168,090 New
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$3.52M +$2.45M +116,400 +303%
BC
32
Blackcrane Capital
Washington
$2.91M -$303K -14,396 -10%
Rafferty Asset Management
33
Rafferty Asset Management
New York
$2.63M +$2.43M +115,419 New
Fidelity Investments
34
Fidelity Investments
Massachusetts
$2.52M -$1.82M -86,623 -44%
Northern Trust
35
Northern Trust
Illinois
$2.06M +$18.8K +892 +1%
SF
36
Synovus Financial
Georgia
$2.02M +$232K +11,030 +14%
ACM
37
ACT Capital Management
Pennsylvania
$1.99M +$1.84M +87,500 New
IHAM
38
Integral Health Asset Management
New York
$1.94M +$421K +20,000 +31%
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.82M -$56.8K -2,700 -3%
RJA
40
Raymond James & Associates
Florida
$1.71M -$3.05K -145 -0.2%
TIP
41
Torray Investment Partners
Maryland
$1.68M +$220K +10,463 +17%
UBS Group
42
UBS Group
Switzerland
$1.64M -$1.02M -48,614 -40%
Arrowstreet Capital
43
Arrowstreet Capital
Massachusetts
$1.59M +$1.47M +69,800 New
Jane Street
44
Jane Street
New York
$1.53M +$76.5K +3,638 +6%
N
45
Nuveen
North Carolina
$1.5M +$1.39M +65,856 New
LBA
46
Letko, Brosseau & Associates
Quebec, Canada
$1.44M – – –
CAPTRUST Financial Advisors
47
CAPTRUST Financial Advisors
North Carolina
$1.02M +$21K +1,000 +2%
TFO
48
Tarbox Family Office
California
$957K +$884K +42,040 New
Cambridge Investment Research Advisors
49
Cambridge Investment Research Advisors
Iowa
$888K +$7.36K +350 +0.9%
Rockefeller Capital Management
50
Rockefeller Capital Management
New York
$785K +$202K +9,600 +39%
1
2
3 4 5

MYOV Hedge Fund Activity: Q2 2021 in Review

108 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q2 2021, worth a combined $737M — up 18% from $624M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new MYOV positions and 19 closed out — a net gain of 4 holders — while 40 added to existing stakes and 27 trimmed.

The largest buyer was State Street, adding an estimated $44.4M. The largest seller was Lord, Abbett & Co, cutting an estimated $27.6M.

  • 108 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q2 2021, up from 104 in Q1 2021.
  • Funds reported $737M of Myovant Sciences Ltd. stock for Q2 2021, up 18% quarter-over-quarter.
  • 23 funds opened new Myovant Sciences Ltd. positions in Q2 2021 and 19 closed out, a net change of +4 holders.
  • The largest Myovant Sciences Ltd. buyer in Q2 2021 was State Street, an estimated $44.4M added.
  • The largest Myovant Sciences Ltd. seller in Q2 2021 was Lord, Abbett & Co, an estimated $27.6M sold.

Based on aggregated 13F filings for Q2 2021.